Spontaneous Right Ventricular Pseudoaneurysms and Increased Arrhythmogenicity in a Mouse Model of Marfan Syndrome
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Patients with Marfan syndrome (MFS), a connective tissue disorder caused by pathogenic variants in the gene encoding the extracellular matrix protein fibrillin-1, have an increased prevalence of primary cardiomyopathy, arrhythmias, and sudden cardiac death. We have performed an in-depth in vivo and ex vivo study of the cardiac phenotype of mice, an established mouse model of MFS with a severely reduced expression of fibrillin-1. Using ultrasound measurements, we confirmed the presence of aortic dilatation and observed cardiac diastolic dysfunction in male mice. Upon post-mortem examination, we discovered that the mutant mice consistently presented myocardial lesions at the level of the right ventricular free wall, which we characterized as spontaneous pseudoaneurysms. Histological investigation demonstrated a decrease in myocardial compaction in the MFS mouse model. Furthermore, continuous 24 h electrocardiographic analysis showed a decreased heart rate variability and an increased prevalence of extrasystolic arrhythmic events in mice compared to wild-type littermates. Taken together, in this paper we document a previously unreported cardiac phenotype in the MFS mouse model and provide a detailed characterization of the cardiac dysfunction and rhythm disorders which are caused by fibrillin-1 deficiency. These findings highlight the wide spectrum of cardiac manifestations of MFS, which might have implications for patient care.
Connell P, Morris S, Doan T, Weigand J Pediatr Cardiol. 2023; 44(7):1536-1545.
PMID: 37505267 DOI: 10.1007/s00246-023-03232-8.
An Overview of Investigational and Experimental Drug Treatment Strategies for Marfan Syndrome.
Deleeuw V, De Clercq A, De Backer J, Sips P J Exp Pharmacol. 2021; 13:755-779.
PMID: 34408505 PMC: 8366784. DOI: 10.2147/JEP.S265271.
Cardiomyopathy in Genetic Aortic Diseases.
Muino-Mosquera L, De Backer J Front Pediatr. 2021; 9:682390.
PMID: 34336739 PMC: 8319542. DOI: 10.3389/fped.2021.682390.